Association of monocyte CCR2 expression with obesity and insulin resistance in postmenopausal women

Clinical and Investigative Medicine

Volumn 36, Issue 1, 2013, Pages

  Jaksic, Vlatka Pandzic ^a   Gizdic, Branimir ^a   Miletic, Zorana ^a   Trutin Ostovic, Karmen ^a   Jaksic, Ozren ^a  

^a University of Zagreb School of Medicine   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CCR2 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR2;

AGED; ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MONOCYTE; OBESITY; PHYSIOLOGY; POSTMENOPAUSE;

AGED; FEMALE; FLOW CYTOMETRY; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; MONOCYTES; OBESITY; POSTMENOPAUSE; RECEPTORS, CCR2;

EID: 84874989139     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
2. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J Clin Invest 2003;112:1821-1830.
3. Surmi BK, Hasty AH. The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue. Vascul Pharmacol 2010;52:27-36.
4. Imhof BA, Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004;4:432-444.
5. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW, Jr. CCR2 modulates in- flammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124.
6. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006;211:609-618.
7. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P. Understanding weight gain at menopause. Climacteric 2012;15:419-429.
8. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proin flammatory state. Circulation 2004;110:1564-1571.
9. Zouaoui BK, Gregoir C, Guillaume M, Remacle C, Piro P, Garbar C, Ducobu J, Moguilevsky N, Vanhaeverbeek M, Delree P, Brohee D. Antigens and granularity of blood monocytes in relation to inflammatory markers and lipids in postmenopausal women. Maturitas 2006;55:132-141.
10. Pandzic Jaksic, V, Gizdic B, Miletic Z, Ostovic KT, Jaksic O. Monocytes in metabolic disorders--opportunities for flow cytometry contributions. Coll Antropol 2010;34:319-325.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
12. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983;130:1910-1917.
13. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH, Jr., Howard BV, Assaf AR, Prentice R. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500-508.
14. Kullo IJ, Hensrud DD, Allison TG. Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, > or =30). Am J Cardiol 2002;89:1441-1443.
15. Targher G, Seidell JC, Tonoli M, Muggeo M, De SG, Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 1996;239:435-441.
16. Waterhouse DF, Cahill RA, Sheehan F, McCreery C. Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population. Vasc Health Risk Manag 2008;4:177-187.
17. Poitou C, Dalmas E, Renovato M, Benhamo V, Hajduch F, Abdennour M, Kahn JF, Veyrie N, Rizkalla S, Fridman WH, Sautes-Fridman C, Clement K, Cremer I. CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 2011;31:2322-2330.
18. Mine S, Okada Y, Tanikawa T, Kawahara C, Tabata T, Tanaka Y. Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem Biophys Res Commun 2006;344:780-785.
19. Huber J, Kiefer FW, Zeyda M, Ludvik B, Silberhumer GR, Prager G, Zlabinger GJ, Stulnig TM. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab 2008;93:3215-3221.
20. Lumeng CN, DeYoung SM, Bodzin JL, Saltiel AR. Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity. Diabetes 2007;56:16-23.
21. Chen A, Mumick S, Zhang C, Lamb J, Dai H, Weingarth D, Mudgett J, Chen H, MacNeil DJ, Reitman ML, Qian S. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res 2005;13:1311-1320.
22. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW, Jr. CCR2 modulates in- flammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124.
23. Guri AJ, Hontecillas R, Ferrer G, Casagran O, Wankhade U, Noble AM, Eizirik DL, Ortis F, Cnop M, Liu D, Si H, Bassaganya-Riera J. Loss of PPAR gamma in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue. J Nutr Biochem 2008;19:216-228.
24. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with antiin flammatory properties. Cell Metab 2007;6:137-143.
25. Degasperi GR, Denis RG, Morari J, Solon C, Geloneze B, Stabe C, Pareja JC, Vercesi AE, Velloso LA. Reactive oxygen species production is increased in the peripheral blood monocytes of obese patients. Metabolism 2009;58:1087-1095.
26. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006;30:400-418.
27. Saccani A, Saccani S, Orlando S, Sironi M, Bernasconi S, Ghezzi P, Mantovani A, Sica A. Redox regulation of chemokine receptor expression. Proc Natl Acad Sci U S A 2000;97:2761-2766.
28. Von Knethen AA, Brune B. Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages. FASEB J 2001;15:535-544.
29. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto JP, Morrow DA, de Lemos JA. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004;44:1812-1818.
30. Sukumar D, Partridge NC, Wang X, Shapses SA. The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity. J Clin Endocrinol Metab 2011;96:1852-1858.
31. Browning LM, Krebs JD, Magee EC, Fruhbeck G, Jebb SA. Circulating markers of inflammation and their link to indices of adiposity. Obes Facts 2008;1:259-265.